Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Accounts Payables (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Accounts Payables for 3 consecutive years, with $9.5 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 49.32% to $9.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2025, up 49.32% year-over-year, with the annual reading at $9.5 million for FY2025, 49.32% up from the prior year.
  • Accounts Payables for Q4 2025 was $9.5 million at Nuvation Bio, down from $15.4 million in the prior quarter.
  • The five-year high for Accounts Payables was $22.4 million in Q2 2025, with the low at $2.2 million in Q4 2023.
  • Average Accounts Payables over 3 years is $7.9 million, with a median of $5.8 million recorded in 2024.
  • Peak annual rise in Accounts Payables hit 421.7% in 2024, while the deepest fall reached 17.28% in 2024.
  • Over 3 years, Accounts Payables stood at $2.2 million in 2023, then soared by 187.37% to $6.3 million in 2024, then soared by 49.32% to $9.5 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $9.5 million, $15.4 million, and $22.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.